Product
UT-15C
Aliases
treprostinil diethanolamine, sustained release, UT-15C SR
2 clinical trials
1 indication
Indication
Pulmonary Arterial HypertensionClinical trial
A Pharmacokinetic Substudy of Subjects Transitioning From Twice Daily to Three Times Daily Dosing of UT-15C SR (Treprostinil Diethanolamine) in the TDE-PH-304 ProtocolStatus: Completed, Estimated PCD: 2013-11-01
Clinical trial
An Evaluation of the Safety and Efficacy of the Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®Status: Completed, Estimated PCD: 2013-11-01